Vector Science and Therapeutics Corp. (VSCTF)

Market Cap	213.45M +192,323.6%
Revenue (ttm)	n/a
Net Income	-898.01K
EPS	-0.13
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,500
Open	1.400
Previous Close	n/a
Day's Range	1.400 - 1.400
52-Week Range	1.400 - 1.600
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About VSCTF

Vector Science and Therapeutics Corp. develops and sells novel biomechanical devices and active localized drug-delivery platforms. The company offers products and services based on its Smart, Steered, and Sustained framework for site-directed interventions in musculoskeletal tissue regeneration. The company has a development and manufacturing agreement with MPP Group LLC to develop and manufacture pharmaceutical-grade peptides and drug delivery devices. The company is based in Mequon, Wisconsin.

• Industry: Biological Products, Except Diagnostic Substances
• CEO: William Jackson
• Country: Canada
• Stock Exchange: OTCMKTS
• Ticker Symbol: VSCTF

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 26, 2026

Data Sources Report a data error